U.S. stocks pre-market movers | Ferrari rises 3.3% pre-market, Q2 earnings report due Thursday, focus on new all-electric models and limited editions

格隆汇2026/07/27 09:15

Show original

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Glonhui July 27｜Luxury car manufacturer Ferrari rose 3.38% in pre-market trading. The company will release its earnings report directly related to this on July 30 (Thursday this week), and the market is pricing ahead. Prior to this, several institutions have expressed positive expectations for the upcoming earnings report, which may be the core driver behind the rise in stock price. In addition to robust financial data, the market is also focusing on management's comments regarding the response to the launch of the new all-electric Ferrari Luce, as well as the potential growth brought by new products such as the limited edition 12Cilindri Manuale.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

NAION is an eye disease that can cause sudden, painless loss of vision, with some patients potentially experiencing permanent visual impairment. The drugs involved include products from Eli Lilly and Novo Nordisk. According to analysts at Citi, the incidence of NAION is relatively low, and given the significant benefits of GLP-1 drugs in weight control and blood sugar management, the actual impact on prescription behavior is expected to be limited. On Monday, the stock prices of Eli Lilly and Novo Nordisk increased, with the news not causing any significant impact on their share prices.

华尔街见闻•2026/11/09 22:12

CleanSpark presents fully funded Sandersville project in investor presentation

Bitget•2026/11/09 22:01